Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp (HAE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 313143.
Total stock buying since 2014: $2,423,480.
Total stock sales since 2014: $117,261,539.
Total stock option exercises since 2014: $45,452,203.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 0 | $0 | 38,339 | $3,463,122 | 109,167 | $4,617,635 |
2023 | 0 | $0 | 22,518 | $1,982,726 | 208,567 | $6,304,686 |
2022 | 0 | $0 | 347,292 | $26,657,770 | 265,710 | $12,102,291 |
2021 | 0 | $0 | 73,005 | $6,256,396 | 57,986 | $2,210,283 |
2020 | 4,000 | $323,720 | 144,116 | $13,112,950 | 14,474 | $604,744 |
2019 | 0 | $0 | 292,546 | $33,522,423 | 71,638 | $2,947,916 |
2018 | 0 | $0 | 115,174 | $12,058,890 | 74,939 | $2,804,531 |
2017 | 0 | $0 | 143,148 | $6,548,301 | 136,879 | $4,682,353 |
2016 | 60,000 | $2,099,760 | 25,056 | $912,447 | 20,338 | $583,166 |
2015 | 0 | $0 | 208,434 | $8,620,345 | 205,637 | $5,689,540 |
2014 | 0 | $0 | 118,607 | $4,126,169 | 115,927 | $2,905,058 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-10-01 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 7,164 | 126.67 | 907,478 |
2019-10-01 | Burke William P. Mr. (EVP, Chief Financial Officer) | Option Ex | 5,718 | 41.64 | 238,097 |
2019-09-09 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 1,531 | 127.44 | 195,110 |
2019-09-09 | Scanlan Jacqueline (SVP, Global Human Resources) | Option Ex | 1,308 | 93.52 | 122,324 |
2019-09-05 | Llorens Josep (SVP, Global Manufacturing) | Sale | 101 | 129.94 | 13,123 |
2019-08-30 | Bolorforosh Said (EVP, Chief Technology Officer) | Sale | 657 | 133.73 | 87,860 |
2019-08-30 | Bolorforosh Said (EVP, Chief Technology Officer) | Option Ex | 832 | 93.52 | 77,808 |
2019-08-19 | Simon, Christopher (President & CEO) | Sale | 50,869 | 137.43 | 6,990,926 |
2019-08-09 | Goldstein Dan (VP, Corporate Controller) | Sale | 475 | 133.23 | 63,284 |
2019-08-09 | Goldstein Dan (VP, Corporate Controller) | Option Ex | 475 | 93.52 | 44,422 |
2019-08-08 | Gelbman Ronald G (Director) | Sale | 1,696 | 134.15 | 227,518 |
2019-07-01 | Simon, Christopher (President & CEO) | Sale | 5,008 | 121.79 | 609,924 |
2019-06-17 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 3,646 | 112.49 | 410,138 |
2019-06-17 | Scanlan Jacqueline (SVP, Global Human Resources) | Option Ex | 2,890 | 41.64 | 120,339 |
2019-06-13 | Goldstein Dan (VP, Corporate Controller) | Sale | 94 | 110.58 | 10,394 |
2019-06-12 | Bolorforosh Said (EVP, Chief Technology Officer) | Sale | 69 | 109.37 | 7,546 |
2019-06-12 | Goldstein Dan (VP, Corporate Controller) | Sale | 39 | 109.37 | 4,265 |
2019-06-12 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 108 | 109.37 | 11,811 |
2019-06-12 | Basil Michelle L (EVP and General Counsel) | Sale | 231 | 109.37 | 25,264 |
2019-06-12 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 190 | 109.37 | 20,780 |
2019-06-12 | Simon, Christopher (President & CEO) | Sale | 1,248 | 109.37 | 136,493 |
2019-06-10 | Goldstein Dan (VP, Corporate Controller) | Sale | 192 | 104.38 | 20,040 |
2019-06-07 | Goldstein Dan (VP, Corporate Controller) | Sale | 78 | 103.38 | 8,063 |
2019-06-07 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 208 | 103.38 | 21,503 |
2019-06-07 | Basil Michelle L (EVP and General Counsel) | Sale | 7,187 | 103.44 | 743,423 |
2019-06-07 | Basil Michelle L (EVP and General Counsel) | Option Ex | 4,872 | 38.43 | 187,230 |
2019-06-07 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 411 | 103.38 | 42,489 |
2019-06-07 | Simon, Christopher (President & CEO) | Sale | 2,834 | 103.38 | 292,978 |
2019-06-06 | Goldstein Dan (VP, Corporate Controller) | Sale | 1,107 | 103.25 | 114,297 |
2019-06-06 | Goldstein Dan (VP, Corporate Controller) | Option Ex | 1,107 | 41.64 | 46,095 |
2019-06-06 | Basil Michelle L (EVP and General Counsel) | Sale | 6,148 | 103.25 | 634,781 |
2019-06-06 | Basil Michelle L (EVP and General Counsel) | Option Ex | 6,148 | 41.64 | 256,002 |
2019-05-23 | Simon, Christopher (President & CEO) | Sale | 24,412 | 99.39 | 2,426,308 |
2019-05-14 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 1,508 | 100.00 | 150,800 |
2019-05-14 | Scanlan Jacqueline (SVP, Global Human Resources) | Option Ex | 1,299 | 38.43 | 49,920 |
2019-05-13 | Simon, Christopher (President & CEO) | Sale | 57,587 | 94.51 | 5,442,547 |
2019-04-09 | Goldstein Dan (VP, Corporate Controller) | Sale | 389 | 88.99 | 34,617 |
2019-04-08 | Goldstein Dan (VP, Corporate Controller) | Sale | 2,817 | 88.62 | 249,642 |
2019-04-08 | Goldstein Dan (VP, Corporate Controller) | Option Ex | 2,607 | 34.42 | 89,732 |
2019-03-07 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 116 | 83.57 | 9,694 |
2019-03-07 | Basil Michelle L (EVP and General Counsel) | Sale | 391 | 83.57 | 32,675 |
2019-02-15 | Gelbman Ronald G (Director) | Sale | 8,196 | 86.52 | 709,117 |
2019-02-15 | Gelbman Ronald G (Director) | Option Ex | 8,196 | 36.37 | 298,088 |
2018-12-14 | Meelia Richard J (Director) | Sale | 8,196 | 102.86 | 843,040 |
2018-12-14 | Meelia Richard J (Director) | Option Ex | 8,196 | 36.37 | 298,088 |
2018-12-14 | Gelbman Ronald G (Director) | Sale | 4,329 | 103.02 | 445,973 |
2018-12-12 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 1,027 | 104.22 | 107,033 |
2018-12-10 | Goldstein Dan (VP, Corporate Controller) | Sale | 1,693 | 102.91 | 174,226 |
2018-12-10 | Goldstein Dan (VP, Corporate Controller) | Option Ex | 1,457 | 34.21 | 49,843 |
2018-11-08 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 13,056 | 114.33 | 1,492,692 |
2018-11-08 | Burke William P. Mr. (EVP, Chief Financial Officer) | Option Ex | 11,232 | 34.21 | 384,246 |
2018-11-08 | Granadillo Pedro P (Director) | Sale | 12,322 | 114.50 | 1,410,869 |
2018-11-07 | Kroll Mark W (Director) | Sale | 10,707 | 114.00 | 1,220,598 |
2018-11-07 | Kroll Mark W (Director) | Option Ex | 8,196 | 36.37 | 298,088 |
2018-10-26 | Goldstein Dan (VP, Corporate Controller) | Sale | 102 | 101.69 | 10,372 |
2018-10-26 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 779 | 101.69 | 79,216 |
2018-09-17 | Granadillo Pedro P (Director) | Sale | 30,824 | 111.54 | 3,437,985 |
2018-09-17 | Granadillo Pedro P (Director) | Option Ex | 25,122 | 39.11 | 982,446 |
2018-09-10 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 4,890 | 112.19 | 548,609 |
2018-09-10 | Scanlan Jacqueline (SVP, Global Human Resources) | Option Ex | 4,188 | 40.03 | 167,666 |
2018-07-02 | Simon, Christopher (President & CEO) | Sale | 5,139 | 89.31 | 458,964 |
2018-06-25 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 6,687 | 92.17 | 616,340 |
2018-06-25 | Burke William P. Mr. (EVP, Chief Financial Officer) | Option Ex | 5,717 | 41.64 | 238,055 |
2018-06-08 | Goldstein Dan (VP, Corporate Controller) | Sale | 578 | 92.90 | 53,696 |
2018-06-07 | Goldstein Dan (VP, Corporate Controller) | Sale | 81 | 92.73 | 7,511 |
2018-06-07 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 214 | 92.73 | 19,844 |
2018-06-07 | Basil Michelle L (EVP and General Counsel) | Sale | 457 | 92.73 | 42,377 |
2018-06-07 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 425 | 92.73 | 39,410 |
2018-06-07 | Simon, Christopher (President & CEO) | Sale | 1,941 | 92.73 | 179,988 |
2018-06-07 | Ryding Neil Mr. (EVP, Global Manufacturing) | Sale | 183 | 92.73 | 16,969 |
2018-06-06 | Goldstein Dan (VP, Corporate Controller) | Sale | 3,713 | 95.14 | 353,254 |
2018-06-06 | Goldstein Dan (VP, Corporate Controller) | Option Ex | 3,713 | 38.03 | 141,205 |
2018-04-06 | Goldstein Dan (VP, Corporate Controller) | Sale | 210 | 72.19 | 15,159 |
2018-03-06 | Scanlan Jacqueline (SVP, Global Human Resources) | Sale | 114 | 72.23 | 8,234 |
2018-03-06 | Basil Michelle L (EVP and General Counsel) | Sale | 389 | 72.23 | 28,097 |
2018-01-02 | Kroll Mark W (Director) | Sale | 7,118 | 63.00 | 448,434 |
2018-01-02 | Kroll Mark W (Director) | Option Ex | 7,118 | 34.41 | 244,894 |
2017-12-01 | Granadillo Pedro P (Director) | Sale | 7,118 | 57.09 | 406,331 |
2017-12-01 | Granadillo Pedro P (Director) | Option Ex | 7,118 | 34.41 | 244,894 |
2017-11-16 | Gelbman Ronald G (Director) | Sale | 5,440 | 56.68 | 308,350 |
2017-11-16 | Gelbman Ronald G (Director) | Option Ex | 7,118 | 34.41 | 244,894 |
2017-11-14 | Burke Willaim P (EVP, Chief Financial Officer) | Sale | 13,193 | 54.19 | 714,862 |
2017-11-14 | Burke Willaim P (EVP, Chief Financial Officer) | Option Ex | 11,231 | 34.21 | 384,212 |
2017-11-13 | Goldstein Dan (Chief Accounting Officer) | Sale | 4,691 | 54.91 | 257,606 |
2017-11-13 | Goldstein Dan (Chief Accounting Officer) | Option Ex | 4,063 | 34.31 | 139,421 |
2017-11-10 | Foote Susan Bartlett (Director) | Sale | 16,926 | 54.22 | 917,727 |
2017-11-10 | Foote Susan Bartlett (Director) | Option Ex | 16,926 | 40.48 | 685,096 |
2017-10-25 | Goldstein Dan (VP, Corporate Controller) | Sale | 111 | 46.76 | 5,190 |
2017-10-25 | Burke William P. Mr. (EVP, Chief Financial Officer) | Sale | 841 | 46.76 | 39,325 |
2017-10-25 | Ryding Neil Mr. (EVP, Global Manufacturing) | Sale | 267 | 46.76 | 12,484 |
2017-10-20 | Ryding Neil Mr. (EVP, Global Manufacturing) | Sale | 346 | 45.70 | 15,812 |
2017-08-10 | Meelia Richard J (Director) | Sale | 24,086 | 42.06 | 1,013,105 |
2017-08-10 | Meelia Richard J (Director) | Option Ex | 24,086 | 33.68 | 811,288 |
2017-07-19 | Goldstein Dan (VP, Corporate Controller) | Sale | 197 | 40.39 | 7,956 |
2017-06-29 | Simon, Christopher (President & CEO) | Sale | 3,595 | 40.39 | 145,202 |
2017-05-22 | Merriman Ronald (Director) | Sale | 25,667 | 40.32 | 1,034,912 |
2017-05-22 | Merriman Ronald (Director) | Option Ex | 25,667 | 34.41 | 865,091 |
2017-05-15 | Kroll Mark W (Director) | Sale | 8,580 | 41.49 | 355,992 |
2017-05-15 | Kroll Mark W (Director) | Option Ex | 8,580 | 27.24 | 233,719 |
2017-05-11 | Foote Susan Bartlett (Director) | Sale | 15,314 | 41.78 | 639,818 |
2017-05-11 | Foote Susan Bartlett (Director) | Option Ex | 15,314 | 35.39 | 541,931 |
2017-03-24 | Gelbman Ronald G (Director) | Sale | 8,580 | 40.00 | 343,200 |
2017-03-24 | Gelbman Ronald G (Director) | Option Ex | 8,580 | 27.24 | 233,719 |
2016-12-12 | Gelbman Ronald G (Director) | Sale | 5,683 | 40.30 | 229,024 |
2016-10-20 | Ryding Neil Mr. (EVP, Global Manufacturing) | Sale | 351 | 34.16 | 11,990 |
2016-08-17 | Merriman Ronald (Director) | Sale | 4,337 | 35.15 | 152,436 |
2016-08-05 | Foote Susan Bartlett (Director) | Sale | 14,685 | 35.34 | 518,997 |
2016-08-05 | Foote Susan Bartlett (Director) | Option Ex | 8,580 | 27.24 | 233,719 |
2016-08-04 | Simon, Christopher (President & CEO) | Buy | 60,000 | 35.00 | 2,099,760 |
2016-07-29 | Gelbman Ronald G (Director) | Option Ex | 11,758 | 29.72 | 349,447 |
2015-10-26 | Selman Byron (President, Global Markets) | Sale | 344 | 32.13 | 11,052 |
2015-10-26 | Jesse Sandra (EVP and Chief Legal Officer) | Sale | 778 | 32.13 | 24,996 |
2015-10-26 | White Jonathan (Chief Science and Technology) | Sale | 319 | 32.13 | 10,249 |
2015-10-26 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 436 | 32.13 | 14,008 |
2015-10-26 | Hanlon Susan M (VP Finance) | Sale | 497 | 32.13 | 15,968 |
2015-10-23 | Selman Byron (President, Global Markets) | Sale | 191 | 31.75 | 6,064 |
2015-10-23 | Jesse Sandra (EVP and Chief Legal Officer) | Sale | 250 | 31.75 | 7,937 |
2015-10-23 | White Jonathan (Chief Science and Technology) | Sale | 250 | 31.75 | 7,937 |
2015-10-23 | Davies Kent J (Chief Operating Officer) | Sale | 278 | 31.75 | 8,826 |
2015-10-23 | Burns Brian R (EVP, Global QA/RA) | Sale | 249 | 31.75 | 7,905 |
2015-10-23 | Hanlon Susan M (VP Finance) | Sale | 162 | 31.75 | 5,143 |
2015-09-15 | Concannon Brian (President & CEO) | Sale | 6,569 | 35.15 | 230,900 |
2015-09-15 | Concannon Brian (President & CEO) | Option Ex | 6,569 | 27.69 | 181,895 |
2015-09-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 35.63 | 169,791 |
2015-09-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-08-20 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 38.49 | 188,687 |
2015-08-20 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-08-17 | Concannon Brian (President & CEO) | Sale | 6,569 | 39.28 | 258,017 |
2015-08-17 | Concannon Brian (President & CEO) | Option Ex | 6,569 | 27.68 | 181,862 |
2015-08-03 | Concannon Brian (President & CEO) | Sale | 4,765 | 39.91 | 190,190 |
2015-08-03 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-07-23 | Davies Kent J (President, Global Markets) | Sale | 279 | 39.36 | 10,981 |
2015-07-20 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 39.09 | 191,609 |
2015-07-20 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-07-15 | Concannon Brian (President & CEO) | Sale | 6,569 | 39.59 | 260,092 |
2015-07-15 | Concannon Brian (President & CEO) | Option Ex | 6,569 | 27.68 | 181,862 |
2015-07-06 | Allen Peter M (President, Global Plasma) | Sale | 30,494 | 40.19 | 1,225,645 |
2015-07-06 | Allen Peter M (President, Global Plasma) | Option Ex | 30,494 | 27.27 | 831,723 |
2015-07-02 | White Jonathan (Chief Science and Technology) | Sale | 2,385 | 41.14 | 98,118 |
2015-07-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 41.28 | 196,713 |
2015-07-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-06-22 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 42.51 | 208,393 |
2015-06-22 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-06-15 | Concannon Brian (President & CEO) | Sale | 6,569 | 42.51 | 279,221 |
2015-06-15 | Concannon Brian (President & CEO) | Option Ex | 6,569 | 27.68 | 181,862 |
2015-06-10 | Hanlon Susan M (VP Finance) | Sale | 6,000 | 43.00 | 258,000 |
2015-06-10 | Hanlon Susan M (VP Finance) | Option Ex | 6,000 | 27.50 | 164,970 |
2015-06-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 41.39 | 197,213 |
2015-06-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-05-20 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 41.65 | 204,173 |
2015-05-20 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-05-05 | Hanlon Susan M (VP Finance) | Sale | 4,000 | 40.08 | 160,300 |
2015-05-05 | Hanlon Susan M (VP Finance) | Option Ex | 4,000 | 26.47 | 105,880 |
2015-05-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 40.74 | 194,140 |
2015-05-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-04-20 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 41.55 | 203,678 |
2015-04-20 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-04-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 44.51 | 212,075 |
2015-04-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-03-27 | Hanlon Susan M (VP Finance) | Sale | 7,000 | 43.47 | 304,255 |
2015-03-27 | Hanlon Susan M (VP Finance) | Option Ex | 7,000 | 26.47 | 185,290 |
2015-03-20 | Lindop Christopher J (CFO & EVP Business Development) | Sale | 4,902 | 44.26 | 216,982 |
2015-03-20 | Lindop Christopher J (CFO & EVP Business Development) | Option Ex | 4,902 | 26.32 | 128,996 |
2015-03-10 | Foote Susan Bartlett (Director) | Sale | 11,328 | 43.84 | 496,642 |
2015-03-10 | Foote Susan Bartlett (Director) | Option Ex | 11,328 | 29.23 | 331,117 |
2015-03-05 | Gelbman Ronald G (Director) | Sale | 7,707 | 44.76 | 344,934 |
2015-03-05 | Gelbman Ronald G (Director) | Option Ex | 11,328 | 29.23 | 331,117 |
2015-03-04 | Merriman Ronald (Director) | Sale | 14,258 | 43.80 | 624,471 |
2015-03-04 | Merriman Ronald (Director) | Option Ex | 14,258 | 28.48 | 406,067 |
2015-03-02 | Concannon Brian (President & CEO) | Sale | 4,765 | 44.41 | 211,618 |
2015-03-02 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-02-27 | Kroll Mark W (Director) | Sale | 11,328 | 44.80 | 507,483 |
2015-02-27 | Kroll Mark W (Director) | Option Ex | 11,328 | 29.23 | 331,117 |
2015-02-18 | Granadillo Pedro P (Director) | Sale | 11,328 | 43.45 | 492,156 |
2015-02-18 | Granadillo Pedro P (Director) | Option Ex | 11,328 | 29.23 | 331,117 |
2015-02-02 | Concannon Brian (President & CEO) | Sale | 4,765 | 39.15 | 186,530 |
2015-02-02 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2015-01-02 | Concannon Brian (President & CEO) | Sale | 4,765 | 37.20 | 177,253 |
2015-01-02 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2014-12-01 | Concannon Brian (President & CEO) | Sale | 4,765 | 36.72 | 174,980 |
2014-12-01 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2014-11-03 | Concannon Brian (President & CEO) | Sale | 4,765 | 35.86 | 170,887 |
2014-11-03 | Concannon Brian (President & CEO) | Option Ex | 4,765 | 27.27 | 129,965 |
2014-10-13 | Allen Peter M (President, Global Plasma) | Sale | 36,426 | 35.22 | 1,282,814 |
2014-10-13 | Allen Peter M (President, Global Plasma) | Option Ex | 36,426 | 25.54 | 930,137 |
2014-08-28 | Mcdaniel Kathleen (EVP Global Human Resources) | Sale | 406 | 35.46 | 14,396 |
2014-08-12 | Merriman Ronald (Director) | Sale | 13,602 | 35.81 | 487,114 |
2014-08-12 | Merriman Ronald (Director) | Option Ex | 11,328 | 29.23 | 331,117 |
2014-08-01 | Concannon Brian (President & CEO) | Sale | 4,380 | 35.27 | 154,465 |
2014-08-01 | Concannon Brian (President & CEO) | Option Ex | 4,380 | 25.54 | 111,843 |
2014-07-07 | Granadillo Pedro P (Director) | Sale | 5,837 | 35.95 | 209,863 |
2014-07-07 | Granadillo Pedro P (Director) | Option Ex | 5,837 | 19.95 | 116,471 |
2014-07-01 | Concannon Brian (President & CEO) | Sale | 4,600 | 35.83 | 164,799 |
2014-07-01 | Concannon Brian (President & CEO) | Option Ex | 4,600 | 25.54 | 117,461 |
2014-06-12 | Gelbman Ronald G (Director) | Sale | 9,184 | 34.00 | 312,283 |
2014-06-12 | Gelbman Ronald G (Director) | Option Ex | 9,184 | 24.96 | 229,232 |
2014-06-12 | Best Lawrence C (Director) | Sale | 9,184 | 33.91 | 311,438 |
2014-06-12 | Best Lawrence C (Director) | Option Ex | 9,184 | 24.96 | 229,232 |
2014-06-06 | Granadillo Pedro P (Director) | Sale | 5,837 | 34.69 | 202,503 |
2014-06-06 | Granadillo Pedro P (Director) | Option Ex | 5,837 | 19.95 | 116,471 |
2014-06-02 | Concannon Brian (President & CEO) | Sale | 4,600 | 33.54 | 154,302 |
2014-06-02 | Concannon Brian (President & CEO) | Option Ex | 4,600 | 25.54 | 117,461 |
2014-05-12 | Foote Susan Bartlett (Director) | Sale | 9,184 | 33.16 | 304,550 |
2014-05-12 | Foote Susan Bartlett (Director) | Option Ex | 9,184 | 24.96 | 229,232 |
2014-05-07 | Granadillo Pedro P (Director) | Sale | 5,837 | 31.14 | 181,775 |
2014-05-07 | Granadillo Pedro P (Director) | Option Ex | 5,837 | 19.95 | 116,471 |
Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.